Muscular Dystrophy – Epidemiology – Epidemiology Data Slicer

launch Related Market Assessment Reports

• Nonalcoholic Steatohepatitis – Current Treatment – Detailed, Expanded Analysis: Current Treatment: Physician Insights (US)

  September 2023

• Systemic Lupus Erythematosus – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course, manifestations, and treatment approach can be…

• Glaucoma – Unmet Need – Detailed, Expanded Analysis (US/EU)

  September 2023

  Glaucoma is a progressive disease of the optic nerve caused by high intraocular pressure (IOP); it is one of the leading causes of vision loss in the United States and Europe. The majority of…

• Dry And Wet Age-Related Macular Degeneration – Unmet Need – Detailed, Expanded Analysis: Geographic Atrophy (US/EU)

  September 2023

  Geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD), is a leading cause of visual impairment and blindness in the United States and Europe. Degradation of cells…

• Squamous Cell Carcinoma Of The Head And Neck – Landscape & Forecast – Disease Landscape & Forecast

  The approval of the immune checkpoint inhibitors Keytruda (Merck & Co.) and Opdivo (Bristol Myers Squibb) for recurrent and metastatic disease has transformed the SCCHN therapy market, which is…